Total Payments
$2,570
2024 Payments
$730.52
Companies
27
Transactions
147
Medicare Patients
2,096
Medicare Billing
$144,443
Payment Breakdown by Category
Food & Beverage$2,509 (97.6%)
Education$61.00 (2.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,509 | 146 | 97.6% |
| Education | $61.00 | 1 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $512.17 | 32 | $0 (2024) |
| Astellas Pharma US Inc | $292.72 | 7 | $0 (2024) |
| ABBVIE INC. | $245.30 | 18 | $0 (2024) |
| GlaxoSmithKline, LLC. | $235.92 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $203.33 | 13 | $0 (2024) |
| PFIZER INC. | $145.68 | 8 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $132.43 | 9 | $0 (2023) |
| Xeris Pharmaceuticals, Inc. | $113.69 | 6 | $0 (2023) |
| Lilly USA, LLC | $100.54 | 6 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $89.76 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $730.52 | 40 | Novo Nordisk Inc ($138.67) |
| 2023 | $958.09 | 49 | Astellas Pharma US Inc ($234.19) |
| 2022 | $559.52 | 36 | Novo Nordisk Inc ($183.82) |
| 2021 | $321.62 | 22 | Boehringer Ingelheim Pharmaceuticals, Inc. ($71.11) |
All Payment Transactions
147 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: PAIN | ||||||
| 11/15/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $9.23 | General |
| Category: Obesity | ||||||
| 11/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Cardio-renal | ||||||
| 10/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: Diabetes Care | ||||||
| 10/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: RESPIRATORY | ||||||
| 10/01/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Biological | ||||||
| 09/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Respiratory | ||||||
| 09/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Cardio-renal | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: RESPIRATORY | ||||||
| 09/06/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Diabetes | ||||||
| 08/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: RESPIRATORY | ||||||
| 08/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Hepatitis B Vaccine | ||||||
| 08/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Obesity | ||||||
| 07/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Diabetes Care | ||||||
| 07/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: Diabetes | ||||||
| 07/02/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 638 | 784 | $170,985 | $46,993 |
| 2022 | 16 | 599 | 739 | $111,980 | $42,440 |
| 2021 | 12 | 409 | 531 | $78,880 | $30,617 |
| 2020 | 15 | 450 | 555 | $79,960 | $24,393 |
Total Patients
2,096
Total Services
2,609
Medicare Billing
$144,443
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 69 | 94 | $38,990 | $8,744 | 22.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 132 | $40,040 | $8,674 | 21.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 29 | 30 | $19,630 | $8,453 | 43.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 71 | 71 | $21,910 | $7,298 | 33.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 112 | 144 | $30,480 | $6,961 | 22.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 11 | $7,205 | $1,756 | 24.4% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 24 | 28 | $2,615 | $1,135 | 43.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 29 | 30 | $910.00 | $853.20 | 93.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 20 | 20 | $620.00 | $568.80 | 91.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 16 | 21 | $1,660 | $441.63 | 26.6% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 20 | 20 | $995.00 | $437.19 | 43.9% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2023 | 27 | 28 | $1,120 | $436.80 | 39.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 16 | 18 | $715.00 | $291.96 | 40.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 34 | 36 | $1,470 | $279.58 | 19.0% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 11 | 11 | $1,045 | $219.69 | 21.0% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 12 | 13 | $515.00 | $194.40 | 37.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 40 | 58 | $305.00 | $127.60 | 41.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 19 | $760.00 | $120.48 | 15.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 100 | 167 | $44,255 | $15,383 | 34.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 88 | 125 | $24,375 | $8,004 | 32.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 64 | 64 | $13,440 | $6,775 | 50.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 16 | 16 | $7,840 | $4,454 | 56.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 66 | $9,070 | $2,710 | 29.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 32 | 33 | $1,650 | $900.90 | 54.6% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 21 | 22 | $1,100 | $897.93 | 81.6% |
About Leigh Kennard
Leigh Kennard is a Family healthcare provider based in Seymour, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2009. The National Provider Identifier (NPI) number assigned to this provider is 1861630089.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Leigh Kennard has received a total of $2,570 in payments from pharmaceutical and medical device companies, with $730.52 received in 2024. These payments were reported across 147 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,509).
As a Medicare-enrolled provider, Kennard has provided services to 2,096 Medicare beneficiaries, totaling 2,609 services with total Medicare billing of $144,443. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Seymour, TN
- Active Since 01/26/2009
- Last Updated 01/26/2009
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1861630089
Products in Payments
- Rybelsus (Drug) $229.62
- TRELEGY ELLIPTA (Drug) $215.57
- Veozah (Drug) $214.44
- VRAYLAR (Drug) $164.86
- Ozempic (Drug) $133.10
- Wegovy (Drug) $110.67
- AIRSUPRA (Drug) $104.90
- GVOKE PFS (Drug) $93.56
- Kerendia (Drug) $89.76
- FARXIGA (Drug) $83.66
- MOUNJARO (Drug) $80.80
- UBRELVY (Drug) $64.65
- LEQVIO (Drug) $61.88
- JARDIANCE (Drug) $57.98
- NURTEC ODT (Drug) $51.03
- FREESTYLE LIBRE 3 (Device) $48.54
- OFEV (Drug) $48.29
- ELIQUIS (Drug) $42.12
- COMIRNATY (Biological) $40.88
- Otezla (Drug) $35.91
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Seymour
Elizabeth Tape, N.p, N.P
Family — Payments: $7,586
Family $7,586
Brittany Simpson, Fnp, FNP
Family — Payments: $6,157
Family $6,157
Ms. Tara Pearcy, Aprn, APRN
Family — Payments: $5,227
Family $5,227
Ms. Erin Stuckwish, Fnp, FNP
Family — Payments: $4,144
Family $4,144
Ms. Kirby Stacks, Np-C, NP-C
Family — Payments: $3,696
Family $3,696
Mrs. Brandi Phillips, Aprn, APRN
Family — Payments: $3,546
Family $3,546